Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
From major journals, first or last author from the Institute for Cancer Research
Teles-Reis J, Rusten TE(2026) Tumour-host interactions in Drosophila: mechanisms in the tumour micro- and macroenvironment Mol Oncol(in press) DOI 10.1002/1878-0261.70207, PubMed 41546533
Zhang X, Johannessen B, Kidd SG, Bogaard M, Stranger A, Axcrona U, Axcrona K, Skotheim RI(2026) Cell type composition in bulk prostate cancer tissue is a prognostic biomarker Neoplasia, 72, 101272(in press) DOI 10.1016/j.neo.2026.101272, PubMed 41534468
Choudhury SR, Gupta I, Mills I, Mukhina V, Loginov A, Allor E, Anderson A, Cellini A, Robles C, Dyalram D, Lubek J, Wolf J, Taylor R, Hatten K, Vorobyeva N, Gaykalova DA(2026) HOXC6 overexpression stimulates cell migration and correlates with poor prognosis in head and neck squamous cell carcinoma Cell Mol Life Sci(in press) DOI 10.1007/s00018-025-06039-3, PubMed 41521225
Teles-Reis J, Rusten TE(2026) Tumour-host interactions in Drosophila: mechanisms in the tumour micro- and macroenvironment Mol Oncol(in press) DOI 10.1002/1878-0261.70207, PubMed 41546533
Ianevski A, Nader K, Nguyen J, Sorger H, Timonen S, Julia E, Pölöske D, Spirk K, Wagner C, Jungherz D, Nakano M, Kadambat Nair S, Ianevski P, Kankainen M, Dias D, Cichońska A, Pemovska T, Pirker C, Berger W, Braun T, Moriggl R, Bachy E, Mustjoki S, Herling M, Neubauer HAet al.(2026) Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery Cancer Res, 86(2), 295-309 DOI 10.1158/0008-5472.CAN-25-0881, PubMed 41166698
Moura DS, Lopez-Marti J, Tawbi H, Keung E, Wani K, Lazar A, Wang WL, Ingram DR, Meza-Zepeda LA, Myklebost O, Burgess M, Mondaza-Hernandez JL, Hindi N, Martín-Broto J(2026) Validation of a seven-gene predictive SIGNature for the efficacy of Immuno-Oncology PD-1 inhibitors in patients with Sarcoma (SIGNIOS) Clin Cancer Res(in press) DOI 10.1158/1078-0432.CCR-25-2580, PubMed 41537707